From a safety perspective how do you counsel your patients in whom you are beginning PCSK9 inhibitor therapy?

From a safety perspective how do you counsel your patients in whom you are beginning PCSK9 inhibitor therapy?

CLICK HERE FOR CME CREDIT

From a safety perspective how do you counsel your patients in whom you are beginning PCSK9 inhibitor therapy?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical and Preventive Cardiologist's Perspective

Presenter

Matthew Roe, MD

Matthew Roe, MD

Professor of Medicine Duke Clinical Research Institute Duke University School of Medicine Durham, NC